Tuesday, April 12, 2016

BRIEF-Redhill Biopharma initiates Phase II study of BEKINDA for irritable bowel syndrome

* Initiates Phase II study of BEKINDA for irritable bowel syndrome Source text for Eikon: Further company coverage: (Bengaluru Newsroom)











Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)